XClose

UCL News

Home
Menu

‘Eureka’ moment as scientists discover common drug stops some cancers spreading

7 March 2025

“It will enable us to interpret the results of ongoing clinical trials and work out who is most likely to benefit from aspirin after a cancer diagnosis,” said Professor Ruth Langley (UCL Institute of Clinical Trials and Methodology) on the cancer-fighting properties of aspirin.

Read: Independent, More: Telegraph (£), iNews, Mail Online, Metro, Express, Mirror, Sun, Scotsman, Daily Record, Newsweek